EDC Solutions

  1. Efficiency, Flexibility, And Speed: Building Better Clinical Trials 9/19/2023

    Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.

  2. Risk-Based Monitoring 9/26/2023

    Program, country, and study managers, CRAs, clinical monitors, trial managers, clinical data managers, CROs, and others need informatics solutions that help them focus on sites in greatest need, based on risk.

  3. AI In Clinical Trials: Reporting/Analytics With TrialKit AI 9/9/2024

    Today’s clinical researchers need precise, timely, and reliable solutions for managing huge amounts of diverse data. TrialKit AI is here to meet this demand.

  4. The SaaS Clinical Data Science Platform 4/8/2024

    Signals Clinical streamlines clinical data workflows, reducing the time spent preparing data for analytics. Its comprehensive platform enables the rapid delivery of clinical insights that inform both clinical and operational study decisions.

  5. It's Time To Move Into One Home for Sites 10/7/2025

    Explore a vendor- and sponsor-neutral platform that streamlines trial management by consolidating systems and tasks.

  6. Why Choose TrialKit For Your Clinical Trials? 7/18/2024

    TrialKit supports everything from small biologics trials to large Phase 3 pharmaceutical trials and extensive registry studies, allowing you to capture and manage your clinical trial data as you see fit.

  7. Rave Lite For Phase I Trials 9/12/2024

    Discover a flexible, cost-effective platform tailored to Phase I studies, providing rapid, efficient study builds, seamless transitions, and scalable solutions for early-stage clinical research.

  8. One Home for Sites™ Partnership Program Guide 4/7/2024

    Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.

  9. Feasibility Insights In NSCLC With EGFR Mutations 1/13/2025

    Discover how the sponsor of a NSCLC trial targeting EGFR mutations leveraged customizable simulation tools to forecast enrollment timelines, mitigate site-level risks, and more.

  10. The Hardest Trials Deserve The Easiest Solutions 2/13/2026

    Explore practical ways to simplify complex oncology studies with unified data, streamlined workflows, and more supportive patient and site experiences.